--

It depends on what you mean by transparency. Would the average person understand the intricacies of a Phase III clinical trial? Do people know what the toxic levels of ingredients in vaccines are, or will they be scared of “mercury salts”?

--

--

René F. Najera, MPH, DrPH
René F. Najera, MPH, DrPH

Written by René F. Najera, MPH, DrPH

DrPH in Epidemiology. Public Health Instructor. Father. Husband. "All around great guy." https://linktr.ee/rene.najera

Responses (1)